person

Cintia H.

Country
Spain
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 9 partner sites.

Specializations

Breast Oncology

Specializes in hormone receptor‑positive and HER2‑negative breast cancer from early‑stage to advanced disease.

  • Adjuvant endocrine strategies
  • Targeted therapies for HER2‑low disease
  • Investigation of triple‑negative breast cancer

Research emphasizes biomarker‑driven combinations to extend disease‑free and overall survival.

Hematologic Malignancies

Engages in clinical studies of acute myeloid leukemia, myelodysplastic syndromes, multiple myeloma, and various B‑cell lymphomas.

  • Novel agents for high‑risk MDS
  • Combination regimens in relapsed/refractory multiple myeloma
  • Targeted therapies for chronic lymphocytic leukemia

Efforts focus on improving response durability and addressing treatment‑resistant disease phenotypes.

Lung Cancer

Investigates both non‑small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including molecularly defined subsets.

  • EGFR‑mutated and KRAS‑mutated NSCLC therapies
  • Immunotherapy combinations for extensive‑stage SCLC
  • Biomarker‑guided trials in HER2‑altered NSCLC

Strategic focus is on precision medicine and overcoming resistance mechanisms.

Gastrointestinal & Hepatobiliary Oncology

Addresses malignancies of the stomach, colon, pancreas, and liver, including gastric adenocarcinoma, colorectal cancer, and hepatocellular carcinoma.

  • Targeted therapy for KRAS‑G12C colorectal disease
  • Combination regimens in metastatic pancreatic adenocarcinoma
  • Immunotherapy approaches for advanced gastric cancer

Research aims to integrate molecular profiling with novel therapeutic agents.

Immunology & Autoimmune Disorders

Conducts trials in immune‑mediated conditions such as systemic lupus erythematosus, graft‑versus‑host disease, and severe asthma phenotypes.

  • Biologic modulation of IL‑6 pathways
  • Targeted treatments for eosinophilic severe asthma
  • Therapeutic strategies for chronic graft‑versus‑host disease

Focus is on translating immunologic insights into disease‑modifying interventions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.